Ilse Lamers1, Silke Kelchtermans2, Ilse Baert2, Peter Feys2. 1. Rehabilitation Research Institute, BIOMED-Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. Electronic address: ilse.lamers@uhasselt.be. 2. Rehabilitation Research Institute, BIOMED-Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
Abstract
OBJECTIVE: To provide an overview of applied upper limb outcome measures in multiple sclerosis (MS) according to the International Classification of Functioning, Disability and Health (ICF) levels and to review their psychometric properties in MS. DATA SOURCES: PubMed and Web of Knowledge. STUDY SELECTION: Articles published until June 2013 were selected when written in English, published in the last 25 years, peer reviewed, including >5 persons with MS, and including standardized clinical upper limb outcome measures. Included articles were screened based on title/abstract and full text by 2 independent reviewers. In case of doubt, feedback from a third independent reviewer was obtained. Additionally, references lists were checked for relevant articles. Of the articles, 109 met the selection criteria and were included for data extraction. DATA EXTRACTION: All reported clinical upper limb outcome measures were extracted from the included studies and classified according to the ICF levels by 2 independent reviewers. In addition, available psychometric properties (reliability, validity, responsiveness) in MS were summarized and discussed. DATA SYNTHESIS: A diversity of outcome measures assessing impairments on the body functions and structures level (n=33), upper limb capacity (n=11), and performance (n=8) on the activity level were extracted from 109 articles. Hand grip strength and the nine-hole peg test (NHPT) were the most frequently used outcome measures. However, multiple outcome measures are necessary to encapsulate the multidimensional character of the upper limb function. The psychometric properties were insufficiently documented for most of the outcome measures, except for the NHPT. CONCLUSIONS: The results of this review may help with the selection of appropriate outcome measures and may guide future research regarding the psychometric properties in MS.
OBJECTIVE: To provide an overview of applied upper limb outcome measures in multiple sclerosis (MS) according to the International Classification of Functioning, Disability and Health (ICF) levels and to review their psychometric properties in MS. DATA SOURCES: PubMed and Web of Knowledge. STUDY SELECTION: Articles published until June 2013 were selected when written in English, published in the last 25 years, peer reviewed, including >5 persons with MS, and including standardized clinical upper limb outcome measures. Included articles were screened based on title/abstract and full text by 2 independent reviewers. In case of doubt, feedback from a third independent reviewer was obtained. Additionally, references lists were checked for relevant articles. Of the articles, 109 met the selection criteria and were included for data extraction. DATA EXTRACTION: All reported clinical upper limb outcome measures were extracted from the included studies and classified according to the ICF levels by 2 independent reviewers. In addition, available psychometric properties (reliability, validity, responsiveness) in MS were summarized and discussed. DATA SYNTHESIS: A diversity of outcome measures assessing impairments on the body functions and structures level (n=33), upper limb capacity (n=11), and performance (n=8) on the activity level were extracted from 109 articles. Hand grip strength and the nine-hole peg test (NHPT) were the most frequently used outcome measures. However, multiple outcome measures are necessary to encapsulate the multidimensional character of the upper limb function. The psychometric properties were insufficiently documented for most of the outcome measures, except for the NHPT. CONCLUSIONS: The results of this review may help with the selection of appropriate outcome measures and may guide future research regarding the psychometric properties in MS.
Authors: Shannon Pike; Anne Cusick; Kylie Wales; Lisa Cameron; Lynne Turner-Stokes; Stephen Ashford; Natasha A Lannin Journal: PLoS One Date: 2021-02-11 Impact factor: 3.240
Authors: Scott D Newsome; Gloria von Geldern; Haochang Shou; Moira Baynes; Rhul E R Marasigan; Peter A Calabresi; Kathleen M Zackowski Journal: Mult Scler Relat Disord Date: 2019-05-06 Impact factor: 4.339
Authors: Rosa M Martínez-Piédrola; Cristina García-Bravo; Elisabet Huertas-Hoyas; Patricia Sánchez-Herrera Baeza; Jorge Pérez-Corrales; Carlos Sánchez-Camarero; Marta Pérez-de-Heredia-Torres Journal: Occup Ther Int Date: 2021-08-16 Impact factor: 1.448
Authors: Caroline S Kampshoff; Mai J M Chinapaw; Johannes Brug; Jos W R Twisk; Goof Schep; Marten R Nijziel; Willem van Mechelen; Laurien M Buffart Journal: BMC Med Date: 2015-10-29 Impact factor: 8.775